My watch list
my.bionity.com  
Login  

Cisplatin

News Cisplatin

  • One Drug, Three Action Modes

    Clinicians combat the drug resistances of some cancer types by using a combination of different drugs. To make this approach more effective, chemists have designed a chemical conjugate that can simultaneously attack several cellular targets using different modes of action. Such a single-drug therapy more

  • Revealing the path of a metallodrug in a breast cancer cell

    Some types of cancer cannot be treated with classical chemotherapy. Scientists from Inserm, CNRS, Sorbonne University, PSL university, University Grenoble Alpes and ESRF, the European Synchrotron, are working on a metallorganic molecule as an antitumor drug. Their research has given thorough insight more

  • Fresh insights into light-activated cancer drugs

    Cancer drugs activated by light, minimizing toxic side-effects, are a step closer thanks to new research from University of Warwick and Monash University through the Monash Warwick Alliance Platinum-based chemotherapy drug candidate kills cancer cells in specific targeted areas, and totally inactive more

All news on cisplatin

Publications Cisplatin

All publications on cisplatin

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE